Clinical Trials Sponsored by Institut für Atemwegsforschung GmbH

Total 251 results

Institut für Atemwegsforschung GmbH
UCB Pharma

Completed

Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic Rhinitis

Allergic Rhinitis

China
Institut für Atemwegsforschung GmbH
UCB Pharma

Completed

Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Allergic Rhinitis

Perennial Allergic Rhinitis

Germany
Profil Institut für Stoffwechselforschung GmbH

Terminated

Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion

Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

A Trial Investigating the Influence of Injection Speed and Volume on the Perception of Subcutaneous Injection Pain

Diabetes Mellitus

Germany
IHF GmbH - Institut für Herzinfarktforschung

Recruiting

Post-Market Registry to Evaluate the Safety and Efficacy of the The SUPRAFLEX CRUZ™ Sirolimus Eluting Coronary Stent System in the Treatment of an Octo- and Nonagenerian All-Comer Patient Cohort With Coronary Artery Disease - the Cruz Senior Study

Coronary Disease

Germany
Profil Institut für Stoffwechselforschung GmbH

Active, not recruiting

Clinical Experimental Study to Investigate Specific Features of ClampArt®

Diabetes Mellitus

Germany
IHF GmbH - Institut für Herzinfarktforschung

Completed

Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes (Real-TICA)

Acute Coronary Syndrome (ACS)

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal Impairment

Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1

Diabetes Mellitus

Germany
IHF GmbH - Institut für Herzinfarktforschung

Not yet recruiting

BENTO - Bronchoscopic Lung Volume Reduction in Severe Emphysema Using Thermoablation

Emphysema or Chronic Obstructive Pulmonary Disease

Germany
IHF GmbH - Institut für Herzinfarktforschung

Recruiting

Pulmonary Artery Sensor System Pressure Monitoring to Improve Heart Failure (HF) Outcomes

Heart Failure

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

Validation of the Doubly Labelled Water Method in Subjects With Type 2 Diabetes Mellitus (DLW)

Diabetes

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

Explorative Assessment of Biomarkers in Overweight and Obese Subjects

Prediabetes

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

Empagliflozin and Sympathetic Nerve Traffic

Type 2 Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test (DXM2)

Type 2 Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH

Withdrawn

An Exploratory Clinical Trial to Generate Whole Blood Samples for Analysing Genetic Polymorphisms

Diabetes Type 1 | Prediabetes | Diabetes Type 2
Profil Institut für Stoffwechselforschung GmbH

Completed

Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology

Type 2 Diabetes Mellitus

Germany
AvenCell Europe GmbH
PHARMALOG Institut für klinische Forschung GmbH

Recruiting

Dose-escalating Trial With UniCAR02-T Cells and PSMA Target Module (TMpPSMA) in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSMA Marker

Prostate Cancer

Germany
AvenCell Europe GmbH
PHARMALOG Institut für klinische Forschung GmbH

Recruiting

Dose-escalating Trial With UniCAR02-T Cells and CD123 Target Module (TM123) in Patients With Hematologic and Lymphatic Malignancies

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) | Acute Myeloid Leukemia (AML)

Germany
Institut fur Diabetes Karlsburg GmbH
Beurer GmbH

Completed

System Accuracy of BGM GL60

Diabetes Mellitus

Germany
Institut fur Diabetes Karlsburg GmbH
Beurer GmbH

Completed

System Accuracy of a Blood Glucose Monitoring System GlucoSpark/GlucoScore

Diabetes Mellitus

Germany
IHF GmbH - Institut für Herzinfarktforschung
OrbusNeich

Withdrawn

COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials (COSTA)

Coronary Disease | Stable Angina | Unstable Angina | STEMI | NSTEMI

Germany
Profil Institut für Stoffwechselforschung GmbH
Sanofi

Completed

A Trial Investigating the Accuracy and Precision of the BGStar® and iBGStar® Blood Glucose Meter in Subjects With Type 1 Diabetes

Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH
Sanofi

Completed

Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes

Type 2 Diabetes

Germany
Profil Institut für Stoffwechselforschung GmbH
Sanofi

Completed

Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy Volunteers

Diabetes

Germany
IHF GmbH - Institut für Herzinfarktforschung
Bayer

Completed

Rivaroxaban in Patients With Atrial Fibrillation Undergoing PCI (RIVA-PCI)

Acute Coronary Syndrome | Percutaneous Coronary Intervention | Non-valvular Atrial Fibrillation | Antithrombotic Therapy

Germany
Profil Institut für Stoffwechselforschung GmbH
Pfizer

Terminated

DIATOR-Diabetes Intervention With Atorvastatin

Type 1 Diabetes

Germany
IHF GmbH - Institut für Herzinfarktforschung
Abbott

Recruiting

ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO)

Myocardial Ischemia

Germany
Saniona
Profil Institut für Stoffwechselforschung GmbH

Completed

Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany
Profil Institut für Stoffwechselforschung GmbH
Sanofi

Completed

Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying

Diabetes Mellitus

Germany
Institut für Klinische Krebsforschung IKF GmbH...
Thoraxklinik-Heidelberg gGmbH

Active, not recruiting

Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease (TREASURE)

Thoracic Radiotherapy | Small Cell Lung Cancer Extensive Stage

Germany, Austria
Institut fur Diabetes Karlsburg GmbH
Aktivmed GmbH; Beurer GmbH; IME-DC GmbH; Medisana GmbH

Completed

System Accuracy of 12 Bloog Glucose Monitoring Systems

Diabetes Mellitus

Germany
Institut fur Diabetes Karlsburg GmbH

Completed

User Evaluation of BGM VGM77

Diabetes

Germany
Institut fur Diabetes Karlsburg GmbH

Completed

User Evaluation of BGM JS200B

Diabetes

Germany
Institut fur Diabetes Karlsburg GmbH

Enrolling by invitation

System Accuracy of 14 Blood Glucose Monitoring Systems

Diabetes

Germany
Institut fur Diabetes Karlsburg GmbH

Not yet recruiting

System Accuracy of the Blood Glucose Monitor for Personal Use Contour Care

Diabetes

Germany
Institut fur Diabetes Karlsburg GmbH

Completed

System Accuracy of BGM GL22

Diabetes

Germany
Institut fur Diabetes Karlsburg GmbH

Completed

Blood Glucose Monitoring Systems: Discounter Versus Brand

Diabetes Mellitus

Germany
Institut für Klinische Krebsforschung IKF GmbH...
AstraZeneca; Thoraxklinik-Heidelberg gGmbH

Recruiting

Thoracic Radiotherapy Plus Durvalumab in Elderly and/or Frail NSCLC Stage III Patients Unfit for Chemotherapy (TRADE-hypo)

NSCLC, Stage III

Germany
AIO-Studien-gGmbH
Servier; Institut für Klinisch-Onkologische Forschung der Krankenhaus Nordwest...

Active, not recruiting

Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer (NIFE)

Biliary Tract Cancer | Extrahepatic Bile Duct Carcinoma | Non-Resectable Hepatocellular Carcinoma | Adenocarcinoma Metastatic | Adenocarcinoma of the Biliary Tract | Adenocarinoma Locally Advanced | Intrahepatic Bile Duct Carcinoma

Germany
Biocon Limited
Profil Institut für Stoffwechselforschung GmbH

Completed

Comparision of Pharmacokinetic and Pharmacodynamic of Biocon Insulin N and Humulin® N

Healthy Volunteer

Germany
University of Hohenheim
Institut für Mikroökologie GmbH

Completed

Resistant Starch, Gut Bacteria and Diabetes (RSDD)

Diabetes Mellitus, Type 2 | Pre Diabetes

Germany
Helios Health Institute GmbH
Heart Center Leipzig - University Hospital; IHF GmbH - Institut für Herzinfarktforschung

Active, not recruiting

Extracorporeal Life Support in Cardiogenic Shock (ECLS-SHOCK)

Acute Myocardial Infarction | Cardiogenic Shock

Germany
Spiden AG
Profil Institut für Stoffwechselforschung GmbH

Recruiting

Spiden Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)

Type 1 Diabetes | Type2diabetes

Germany
Zealand Pharma
Profil Institut für Stoffwechselforschung GmbH

Recruiting

A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570

Safety and Tolerability

Germany
Biocon Limited
Profil Institut für Stoffwechselforschung GmbH

Completed

Comparison of the Pharmacokinetic and Pharmacodynamic Properties of Biocon's Insulin R U-500 With Humulin® R U-500 (US Reference Product) in Healthy Subjects (RHINE-4)

Healthy Volunteers

Germany
Biocon Limited
Profil Institut für Stoffwechselforschung GmbH

Completed

Comparision of Pharmacokinetics(PK) and Pharmacodynamics(PD) of Biocon Insulin R and Humulin® R

Healthy Volunteer

Germany
Biocon Limited
Profil Institut für Stoffwechselforschung GmbH

Completed

Comparison of Pharmacokinetic (PK) and Pharmacodynamic(PD) of Biocon Insulin 70/30 and Humulin® 70/30

Healthy Volunteer

Germany
Medtronic Diabetes
Profil Institut für Stoffwechselforschung GmbH

Completed

New Generation Enlite Accuracy Study

Diabetes
Profil Institut für Stoffwechselforschung GmbH
European Union

Completed

Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon Dosages

Diabetes Mellitus Type 1

Germany

Clinical Trials Sponsored by Institut für Atemwegsforschung GmbH

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations